China Feihe Limited (6186) Stock Forecast & Price Target

Compare

13 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

6186 Financial Forecast

6186 Earnings Forecast

Next quarter’s earnings estimate for 6186 is HK$0.17 with a range of HK$0.17 to HK$0.17. The previous quarter’s EPS was HK$0.12. 6186 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.98% of the time in the same period. In the last calendar year 6186 has Performed in-line its overall industry.

6186 Sales Forecast

Next quarter’s sales forecast for 6186 is HK$10.66B with a range of HK$10.66B to HK$10.66B. The previous quarter’s sales results were HK$9.83B. 6186 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 52.41% of the time in the same period. In the last calendar year 6186 has Performed in-line its overall industry.

Detailed List of Analyst Forecasts

Unknown Analyst

Citic Securities

Not Ranked

Citic Securities

HK$5

Buy

23.15%

Upside

Reiterated

09/08/25

Tiffany Feng

Citi

HK$5.5→HK$4.3

Hold

5.91%

Upside

Reiterated

09/01/25

Citi Sticks to Its Hold Rating for China Feihe Limited (6186)Citi analyst Tiffany Feng lowered the price target on China Feihe Limited (6186:HK) (OTC: CFEIY) to HK$4.30 (from HK$5.50) while maintaining a Neutral rating.

Leaf Liu

Goldman Sachs

HK$6.4→HK$4.3

Hold

5.91%

Upside

Downgraded

09/01/25

Cautious Outlook for China Feihe Limited Amid Declining Sales and Profitability ChallengesChina Feihe Ltd. (6186.HK): Lower guidance; focusing on healthier channel mix; downgrade to 2025 | 7:18PM HKT Feihe reported 1H25 earnings on Aug 28, with sales/NP decreased by 9.4%/47% yoy. The company further guided down full-year sales to Rmb21bn (incl. VAT tax) or c. Rmb19bn (post VAT, decline yoy by DD%) with continued destocking into 3Q and a delay in super premium+ product launches. It targets FY25 net profit to stay at c.Rmb2bn as biological/milk powder impairment loss is likely to impact 2H earnings. While we recognize the company's efforts in product mix enhancement (increasing portion of new super-premium SKU "Zhuorui" in its total revenue mix), more resilient online growth, and steady IMF GPM, we expect further destocking into end-2025 and more marketing dollars going forward to regain market share.

Unknown Analyst

CLSA

Not Ranked

CLSA

HK$4.9

Buy

20.69%

Upside

Reiterated

09/01/25

Kevin Yin

J.P. Morgan

HK$6→HK$5.4

Buy

33.00%

Upside

Reiterated

08/30/25

China Feihe Limited (6186) Gets a Buy from J.P. Morgan

Unknown Analyst

UBS

Not Ranked

UBS

HK$6.3

Buy

55.17%

Upside

Reiterated

08/30/25

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

HK$5.23

Buy

28.82%

Upside

Reiterated

08/29/25

Unknown Analyst

HSBC

Not Ranked

HSBC

HK$4.8

Sell

18.23%

Upside

Reiterated

08/29/25

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

HK$5

Hold

23.15%

Upside

Reiterated

08/29/25

Unknown Analyst

UBS

Not Ranked

UBS

HK$7.4

Buy

82.27%

Upside

Reiterated

03/31/25

UBS reiterates Buy Rating on China Feihe Limited (6186:HK) (CFEIY)UBS analyst Mark Yuan reiterated a Buy rating and HK$7.40 price target on China Feihe Limited (6186:HK) (OTC: CFEIY).

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

HK$7.38

Buy

81.77%

Upside

Reiterated

03/30/25

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

HK$7.4

Buy

82.27%

Upside

Reiterated

03/14/25

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Unknown Analyst

Citic Securities

Not Ranked

Citic Securities

HK$5

Buy

23.15%

Upside

Reiterated

09/08/25

Tiffany Feng

Citi

HK$5.5→HK$4.3

Hold

5.91%

Upside

Reiterated

09/01/25

Leaf Liu

Goldman Sachs

HK$6.4→HK$4.3

Hold

5.91%

Upside

Downgraded

09/01/25

Unknown Analyst

CLSA

Not Ranked

CLSA

HK$4.9

Buy

20.69%

Upside

Reiterated

09/01/25

Kevin Yin

J.P. Morgan

HK$6→HK$5.4

Buy

33.00%

Upside

Reiterated

08/30/25

China Feihe Limited (6186) Gets a Buy from J.P. Morgan

Unknown Analyst

UBS

Not Ranked

UBS

HK$6.3

Buy

55.17%

Upside

Reiterated

08/30/25

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

HK$5.23

Buy

28.82%

Upside

Reiterated

08/29/25

Unknown Analyst

HSBC

Not Ranked

HSBC

HK$4.8

Sell

18.23%

Upside

Reiterated

08/29/25

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

HK$5

Hold

23.15%

Upside

Reiterated

08/29/25

Unknown Analyst

UBS

Not Ranked

UBS

HK$7.4

Buy

82.27%

Upside

Reiterated

03/31/25

UBS reiterates Buy Rating on China Feihe Limited (6186:HK) (CFEIY)UBS analyst Mark Yuan reiterated a Buy rating and HK$7.40 price target on China Feihe Limited (6186:HK) (OTC: CFEIY).

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

HK$7.38

Buy

81.77%

Upside

Reiterated

03/30/25

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

HK$7.4

Buy

82.27%

Upside

Reiterated

03/14/25

Stocks with the Highest Top Analyst Consensus in the Consumer Defensive Sector

xxx

Find stocks in the Consumer Defensive sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering China Feihe Limited

1 Month

xxx

Success Rate

1/4 ratings generated profit

Average Return

-3.43%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 25.00% of your transactions generating a profit, with an average return of -3.43% per trade.

3 Months

xxx

Success Rate

1/4 ratings generated profit

Average Return

-8.70%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -8.70% per trade.

1 Year

Kevin YinJ.P. Morgan

Success Rate

0/4 ratings generated profit

Average Return

-18.18%

reiterated a buy rating 4 months ago

Copying Kevin Yin's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -18.18% per trade.

2 Years

xxx

Success Rate

1/4 ratings generated profit

Average Return

-2.35%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -2.35% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

6186 Analyst Recommendation Trends

Rating

Apr 25

Jun 25

Jul 25

Aug 25

Sep 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 6186 has received 5 Buy Ratings, 6 Hold Ratings, and 1 Sell Ratings. 6186 average Analyst price target in the past 3 months is ―.

Each month's total comprises the sum of three months' worth of ratings.

6186 Stock Forecast FAQ

What is HK:6186’s average 12-month price target, according to analysts?

Currently, no data Available

What is HK:6186’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for HK:6186, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is China Feihe Limited a Buy, Sell or Hold?

China Feihe Limited has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.

What is China Feihe Limited’s share price target?

Currently, no data Available

What do analysts say about China Feihe Limited?

China Feihe Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.

How can I buy shares of China Feihe Limited?

To buy shares of HK:6186, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

China Feihe Limited (6186) Stock Forecast & Price Target

6186 Financial Forecast

6186 Earnings Forecast

6186 Sales Forecast

Detailed List of Analyst Forecasts​

Best Analysts Covering China Feihe Limited

6186 Analyst Recommendation Trends

6186 Stock Forecast FAQ

Detailed List of Analyst Forecasts